MYDA Advisors’s Matinas BioPharma MTNB Stock Holding History

MYDA Advisors’s Portfolio MTNB Stock Details MTNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-2,000	Closed	-$105K	–	319
2021 Q1	$105K	Buy	+2,000	New	+$134K	0.03%	271

Other funds holding MTNB

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

CCM

Courage Capital Management Nashville, Tennessee $70.6M AUM 13.29% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

MYDA Advisors's MTNB Position: Q2 2021 in Review

MYDA Advisors sold out of Matinas BioPharma (MTNB) in Q2 2021, closing a stake of 2,000 shares — an estimated $105K sold.

MYDA Advisors first reported a position in MTNB in Q1 2021 and held it in 1 quarter. The position peaked at $105K in Q1 2021. 67 funds tracked by Wall St. Rank hold MTNB as of Q2 2021.

MYDA Advisors reported no remaining Matinas BioPharma position as of Q2 2021 after selling out during the quarter.
MYDA Advisors sold 2,000 Matinas BioPharma shares in Q2 2021, an estimated $105K.
MYDA Advisors first reported a position in Matinas BioPharma in Q1 2021 and held it in 1 quarter.
MYDA Advisors's Matinas BioPharma position peaked at $105K in Q1 2021.
67 funds tracked by Wall St. Rank held Matinas BioPharma as of Q2 2021.

Based on MYDA Advisors's 13F filing for Q2 2021, filed 13 Aug 2021.